Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3164426)

Published in J Infect Dis on October 01, 2011

Authors

Diana C Rosentul1, Theo S Plantinga, Marije Oosting, William K Scott, Digna R Velez Edwards, P Brian Smith, Barbara D Alexander, John C Yang, Gregory M Laird, Leo A B Joosten, Jos W M van der Meer, John R Perfect, Bart-Jan Kullberg, Mihai G Netea, Melissa D Johnson

Author Affiliations

1: Department of Medicine, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.

Articles citing this

The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis. PLoS One (2016) 1.41

Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat Commun (2013) 1.31

The pathogen Candida albicans hijacks pyroptosis for escape from macrophages. MBio (2014) 1.07

Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans. J Immunol (2012) 1.07

Genetic susceptibility to Candida infections. EMBO Mol Med (2013) 1.05

Candida vaginitis: when opportunism knocks, the host responds. PLoS Pathog (2014) 0.92

Dectin-1 is required for resistance to coccidioidomycosis in mice. MBio (2013) 0.92

Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front Microbiol (2014) 0.87

Sepsis induced immunosuppression: Implications for secondary infections and complications. Indian J Crit Care Med (2013) 0.87

Immunity and tolerance to fungi in hematopoietic transplantation: principles and perspectives. Front Immunol (2012) 0.86

Autophagy is redundant for the host defense against systemic Candida albicans infections. Eur J Clin Microbiol Infect Dis (2013) 0.85

Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia. Nat Commun (2014) 0.84

Insights from human studies into the host defense against candidiasis. Cytokine (2011) 0.83

Role of autophagy genetic variants for the risk of Candida infections. Med Mycol (2014) 0.79

Host genetics of invasive Aspergillus and Candida infections. Semin Immunopathol (2014) 0.77

Genetic variants of innate immune receptors and infections after liver transplantation. World J Gastroenterol (2014) 0.77

Antifungal Immunological Defenses in Newborns. Front Immunol (2017) 0.75

Fungal-derived cues promote ocular autoimmunity through a Dectin-2/Card9-mediated mechanism. Clin Exp Immunol (2017) 0.75

Is human Dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis? Curr Med Mycol (2016) 0.75

C-type lectin receptors in tuberculosis: what we know. Med Microbiol Immunol (2016) 0.75

Articles cited by this

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Human non-synonymous SNPs: server and survey. Nucleic Acids Res (2002) 50.45

WHAT IF: a molecular modeling and drug design program. J Mol Graph (1990) 24.35

Toll-like receptors and innate immunity. Nat Rev Immunol (2001) 16.50

Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med (2003) 7.38

Immune recognition. A new receptor for beta-glucans. Nature (2001) 6.54

Dectin-1 mediates the biological effects of beta-glucans. J Exp Med (2003) 5.82

Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature (2006) 5.34

Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med (2009) 5.27

A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med (2009) 5.20

An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol (2008) 5.13

Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol (2006) 4.84

Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest (2006) 4.45

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med (2008) 4.16

Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol (2007) 3.02

Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics (2010) 2.85

Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis (2009) 2.49

Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis (2007) 2.24

Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol (2009) 1.93

Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis (2008) 1.57

Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw (2006) 1.41

Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine (2008) 1.25

Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge. PLoS Pathog (2008) 0.86

Articles by these authors

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis (2008) 20.88

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19

Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95

How should we define health? BMJ (2011) 7.82

Hidden killers: human fungal infections. Sci Transl Med (2012) 7.10

Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet (2011) 6.36

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53

Sports medicine and ethics. Am J Bioeth (2013) 5.51

Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med (2009) 5.27

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis (2005) 5.24

Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature (2005) 5.11

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis (2006) 4.88

Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest (2006) 4.72

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol (2004) 4.70

Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood (2008) 4.63

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum (2004) 4.58

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet (2010) 4.47

Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ (2010) 4.44

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov (2012) 4.40

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet (2010) 4.26

Chronic fatigue syndrome. Lancet (2006) 4.15

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis (2013) 4.14

Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res (2010) 4.14

Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med (2013) 3.81

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A (2012) 3.62

Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect Immun (2003) 3.61

Combination antifungal therapy. Antimicrob Agents Chemother (2004) 3.49

Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet (2008) 3.27

The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis (2007) 3.15

The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab (2010) 3.11

STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med (2011) 3.11

The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe (2009) 3.07

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother (2011) 3.04

Trained immunity: a memory for innate host defense. Cell Host Microbe (2011) 2.94

Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A (2011) 2.92

Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut (2011) 2.91

Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet (2002) 2.90

Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet (2006) 2.89

IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci U S A (2014) 2.86

Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med (2006) 2.86

Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest (2008) 2.82

Cryptococcosis. Infect Dis Clin North Am (2006) 2.82

Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J (2002) 2.81

Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev (2002) 2.79

Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol (2011) 2.75

Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain (2008) 2.75

An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med (2011) 2.70

Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol (2011) 2.70

IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A (2006) 2.67

Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med (2013) 2.65

Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol (2008) 2.62

Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol (2007) 2.60

Between-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med (2015) 2.59

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis (2008) 2.55

IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog (2010) 2.54

Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51

Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr Biol (2009) 2.50

Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis (2009) 2.49

Globalization of pediatric research: analysis of clinical trials completed for pediatric exclusivity. Pediatrics (2010) 2.48

Breakthrough invasive candidiasis in patients on micafungin. J Clin Microbiol (2010) 2.47

Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum (2007) 2.42